{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T19:44:20Z","timestamp":1793994260558,"version":"4.8.0"},"reference-count":140,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T00:00:00Z","timestamp":1719014400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T00:00:00Z","timestamp":1719014400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100012165","name":"Key Technologies Research and Development Program","doi-asserted-by":"publisher","award":["2019YFA0801603"],"award-info":[{"award-number":["2019YFA0801603"]}],"id":[{"id":"10.13039\/501100012165","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>While conventional cancer modalities, such as chemotherapy and radiotherapy, act through direct killing of tumor cells, cancer immunotherapy elicits potent anti-tumor immune responses thereby eliminating tumors. Nevertheless, promising outcomes have not been reported in patients with glioblastoma (GBM) likely due to the immune privileged status of the central nervous system and immunosuppressive micro-environment within GBM. In the past years, several exciting findings, such as the re-discovery of meningeal lymphatic vessels (MLVs), three-dimensional anatomical reconstruction of MLV networks, and the demonstration of the promotion of GBM immunosurveillance by lymphatic drainage enhancement, have revealed an intricate communication between the nervous and immune systems, and brought hope for the development of new GBM treatment. Based on conceptual framework of the updated cancer-immunity (CI) cycle, here we focus on GBM antigen drainage and immune activation, the early events in driving the CI cycle. We also discuss the implications of these findings for developing new therapeutic approaches in tackling fatal GBM in the future.<\/jats:p>","DOI":"10.1007\/s00018-024-05300-5","type":"journal-article","created":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T09:01:52Z","timestamp":1719046912000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Combination of tumor antigen drainage and immune activation to promote a cancer-immunity cycle against glioblastoma"],"prefix":"10.1007","volume":"81","author":[{"given":"Han","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9614-8776","authenticated-orcid":false,"given":"Jincai","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,22]]},"reference":[{"key":"5300_CR1","doi-asserted-by":"publisher","unstructured":"Ostrom QT et al (2022) CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2015\u20132019. Neuro-oncology 24, v1-v95, https:\/\/doi.org\/10.1093\/neuonc\/noac202","DOI":"10.1093\/neuonc\/noac202"},{"key":"5300_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41568-019-0232-7","volume":"20","author":"Focusing on brain tumours and brain metastasis","year":"2020","unstructured":"Focusing on brain tumours and brain metastasis (2020) Nat Rev Cancer 20:1\u20131. https:\/\/doi.org\/10.1038\/s41568-019-0232-7","journal-title":"Nat Rev Cancer"},{"key":"5300_CR3","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1056\/NEJMoa1709684","volume":"377","author":"JD Wolchok","year":"2017","unstructured":"Wolchok JD et al (2017) Overall survival with combined Nivolumab and Ipilimumab in Advanced Melanoma. N Engl J Med 377:1345\u20131356. https:\/\/doi.org\/10.1056\/NEJMoa1709684","journal-title":"N Engl J Med"},{"key":"5300_CR4","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1056\/NEJMoa1910836","volume":"381","author":"J Larkin","year":"2019","unstructured":"Larkin J et al (2019) Five-year survival with combined Nivolumab and Ipilimumab in Advanced Melanoma. N Engl J Med 381:1535\u20131546. https:\/\/doi.org\/10.1056\/NEJMoa1910836","journal-title":"N Engl J Med"},{"key":"5300_CR5","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1056\/NEJMoa1910231","volume":"381","author":"MD Hellmann","year":"2019","unstructured":"Hellmann MD et al (2019) Nivolumab plus Ipilimumab in Advanced Non-small-cell Lung Cancer. N Engl J Med 381:2020\u20132031. https:\/\/doi.org\/10.1056\/NEJMoa1910231","journal-title":"N Engl J Med"},{"key":"5300_CR6","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1093\/neuonc\/noac116","volume":"24","author":"M Lim","year":"2022","unstructured":"Lim M et al (2022) Phase III trial of chemoradiotherapy with temozolomide plus nivolumab or placebo for newly diagnosed glioblastoma with methylated MGMT promoter. Neurooncology 24:1935\u20131949. https:\/\/doi.org\/10.1093\/neuonc\/noac116","journal-title":"Neurooncology"},{"key":"5300_CR7","doi-asserted-by":"publisher","unstructured":"Ma K, Hu P (2023) Chimeric Antigen receptor T-Cell therapy for Glioblastoma. Cancers 15. https:\/\/doi.org\/10.3390\/cancers15235652","DOI":"10.3390\/cancers15235652"},{"key":"5300_CR8","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1001\/jamaoncol.2020.1024","volume":"6","author":"DA Reardon","year":"2020","unstructured":"Reardon DA et al (2020) Effect of Nivolumab vs Bevacizumab in patients with recurrent glioblastoma: the CheckMate 143 phase 3 Randomized Clinical Trial. JAMA Oncol 6:1003\u20131010. https:\/\/doi.org\/10.1001\/jamaoncol.2020.1024","journal-title":"JAMA Oncol"},{"key":"5300_CR9","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/s41591-019-0385-7","volume":"25","author":"H Ito","year":"2019","unstructured":"Ito H, Nakashima H, Chiocca EA (2019) Molecular responses to immune checkpoint blockade in glioblastoma. Nat Med 25:359\u2013361. https:\/\/doi.org\/10.1038\/s41591-019-0385-7","journal-title":"Nat Med"},{"key":"5300_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-02875-1","author":"CE Brown","year":"2024","unstructured":"Brown CE et al (2024) Locoregional delivery of IL-13R\u03b12-targeting CAR-T cells in recurrent high-grade glioma: a phase 1 trial. Nat Med. https:\/\/doi.org\/10.1038\/s41591-024-02875-1","journal-title":"Nat Med"},{"key":"5300_CR11","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1001\/jamaoncol.2022.5370","volume":"9","author":"LM Liau","year":"2023","unstructured":"Liau LM et al (2023) Association of Autologous Tumor Lysate-loaded dendritic cell vaccination with extension of Survival among patients with newly diagnosed and recurrent glioblastoma: a phase 3 prospective externally controlled Cohort Trial. JAMA Oncol 9:112\u2013121. https:\/\/doi.org\/10.1001\/jamaoncol.2022.5370","journal-title":"JAMA Oncol"},{"key":"5300_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.immuni.2013.07.012","volume":"39","author":"DS Chen","year":"2013","unstructured":"Chen DS, Mellman I (2013) Oncology meets immunology: the cancer-immunity cycle. Immunity 39:1\u201310. https:\/\/doi.org\/10.1016\/j.immuni.2013.07.012","journal-title":"Immunity"},{"key":"5300_CR13","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1016\/j.immuni.2023.09.011","volume":"56","author":"I Mellman","year":"2023","unstructured":"Mellman I, Chen DS, Powles T, Turley SJ (2023) The cancer-immunity cycle: indication, genotype, and immunotype. Immunity 56:2188\u20132205. https:\/\/doi.org\/10.1016\/j.immuni.2023.09.011","journal-title":"Immunity"},{"key":"5300_CR14","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nature14432","volume":"523","author":"A Louveau","year":"2015","unstructured":"Louveau A et al (2015) Structural and functional features of central nervous system lymphatic vessels. Nature 523:337\u2013341. https:\/\/doi.org\/10.1038\/nature14432","journal-title":"Nature"},{"key":"5300_CR15","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1084\/jem.20142290","volume":"212","author":"A Aspelund","year":"2015","unstructured":"Aspelund A et al (2015) A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules. J Exp Med 212:991\u2013999. https:\/\/doi.org\/10.1084\/jem.20142290","journal-title":"J Exp Med"},{"key":"5300_CR16","doi-asserted-by":"publisher","first-page":"147ra111","DOI":"10.1126\/scitranslmed.3003748","volume":"4","author":"JJ Iliff","year":"2012","unstructured":"Iliff JJ et al (2012) A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid \u03b2. Sci Transl Med 4:147ra111. https:\/\/doi.org\/10.1126\/scitranslmed.3003748","journal-title":"Sci Transl Med"},{"key":"5300_CR17","doi-asserted-by":"publisher","first-page":"3210","DOI":"10.1172\/jci90603","volume":"127","author":"A Louveau","year":"2017","unstructured":"Louveau A et al (2017) Understanding the functions and relationships of the glymphatic system and meningeal lymphatics. J Clin Investig 127:3210\u20133219. https:\/\/doi.org\/10.1172\/jci90603","journal-title":"J Clin Investig"},{"key":"5300_CR18","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/s1474-4422(18)30318-1","volume":"17","author":"MK Rasmussen","year":"2018","unstructured":"Rasmussen MK, Mestre H, Nedergaard M (2018) The glymphatic pathway in neurological disorders. Lancet Neurol 17:1016\u20131024. https:\/\/doi.org\/10.1016\/s1474-4422(18)30318-1","journal-title":"Lancet Neurol"},{"key":"5300_CR19","doi-asserted-by":"publisher","first-page":"627","DOI":"10.3171\/jns.1980.53.5.0627","volume":"53","author":"S Hill","year":"1980","unstructured":"Hill S, Martin E, Ellison EC, Hunt WE (1980) Carcinoembryonic antigen in cerebrospinal fluid of adult brain-tumor patients. J Neurosurg 53:627\u2013632. https:\/\/doi.org\/10.3171\/jns.1980.53.5.0627","journal-title":"J Neurosurg"},{"key":"5300_CR20","doi-asserted-by":"publisher","unstructured":"Kaur J et al (2023) Imaging glymphatic response to glioblastoma. Cancer Imaging: Official Publication Int Cancer Imaging Soc 23. https:\/\/doi.org\/10.1186\/s40644-023-00628-w","DOI":"10.1186\/s40644-023-00628-w"},{"key":"5300_CR21","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/s41593-020-00789-y","volume":"24","author":"AR Pombo Antunes","year":"2021","unstructured":"Pombo Antunes AR et al (2021) Single-cell profiling of myeloid cells in glioblastoma across species and disease stage reveals macrophage competition and specialization. Nat Neurosci 24:595\u2013610. https:\/\/doi.org\/10.1038\/s41593-020-00789-y","journal-title":"Nat Neurosci"},{"key":"5300_CR22","doi-asserted-by":"publisher","unstructured":"Carenza C et al (2022) Perioperative corticosteroid treatment impairs tumor-infiltrating dendritic cells in patients with newly diagnosed adult-type diffuse gliomas. Front Immunol 13. https:\/\/doi.org\/10.3389\/fimmu.2022.1074762","DOI":"10.3389\/fimmu.2022.1074762"},{"key":"5300_CR23","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1158\/2326-6066.Cir-22-0098","volume":"11","author":"JA Bowman-Kirigin","year":"2023","unstructured":"Bowman-Kirigin JA et al (2023) The conventional dendritic cell 1 subset primes CD8\u2009+\u2009T cells and Traffics Tumor Antigen to drive Antitumor Immunity in the brain. Cancer Immunol Res 11:20\u201337. https:\/\/doi.org\/10.1158\/2326-6066.Cir-22-0098","journal-title":"Cancer Immunol Res"},{"key":"5300_CR24","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1007\/s00018-020-03706-5","volume":"78","author":"ST Proulx","year":"2021","unstructured":"Proulx ST (2021) Cerebrospinal fluid outflow: a review of the historical and contemporary evidence for arachnoid villi, perineural routes, and dural lymphatics. Cell Mol Life Sci 78:2429\u20132457. https:\/\/doi.org\/10.1007\/s00018-020-03706-5","journal-title":"Cell Mol Life Sci"},{"key":"5300_CR25","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1038\/nn.4558","volume":"20","author":"NI Bower","year":"2017","unstructured":"Bower NI et al (2017) Mural lymphatic endothelial cells regulate meningeal angiogenesis in the zebrafish. Nat Neurosci 20:774\u2013783. https:\/\/doi.org\/10.1038\/nn.4558","journal-title":"Nat Neurosci"},{"key":"5300_CR26","doi-asserted-by":"publisher","first-page":"e29738","DOI":"10.7554\/eLife.29738","volume":"6","author":"M Absinta","year":"2017","unstructured":"Absinta M et al (2017) Human and nonhuman primate meninges harbor lymphatic vessels that can be visualized noninvasively by MRI. eLife 6:e29738. https:\/\/doi.org\/10.7554\/eLife.29738","journal-title":"eLife"},{"key":"5300_CR27","doi-asserted-by":"publisher","unstructured":"Jacob L et al (2022) Conserved meningeal lymphatic drainage circuits in mice and humans. J Exp Med 219. https:\/\/doi.org\/10.1084\/jem.20220035","DOI":"10.1084\/jem.20220035"},{"key":"5300_CR28","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1007\/s10143-019-01133-0","volume":"43","author":"R Tamura","year":"2020","unstructured":"Tamura R, Yoshida K, Toda M (2020) Current understanding of lymphatic vessels in the central nervous system. Neurosurg Rev 43:1055\u20131064. https:\/\/doi.org\/10.1007\/s10143-019-01133-0","journal-title":"Neurosurg Rev"},{"key":"5300_CR29","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1038\/s41586-023-06899-4","volume":"625","author":"J-H Yoon","year":"2024","unstructured":"Yoon J-H et al (2024) Nasopharyngeal lymphatic plexus is a hub for cerebrospinal fluid drainage. Nature 625:768\u2013777. https:\/\/doi.org\/10.1038\/s41586-023-06899-4","journal-title":"Nature"},{"key":"5300_CR30","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/s41586-019-1912-x","volume":"577","author":"E Song","year":"2020","unstructured":"Song E et al (2020) VEGF-C-driven lymphatic drainage enables immunosurveillance of brain tumours. Nature 577:689\u2013694. https:\/\/doi.org\/10.1038\/s41586-019-1912-x","journal-title":"Nature"},{"key":"5300_CR31","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/s41422-020-0287-8","volume":"30","author":"X Hu","year":"2020","unstructured":"Hu X et al (2020) Meningeal lymphatic vessels regulate brain tumor drainage and immunity. Cell Res 30:229\u2013243. https:\/\/doi.org\/10.1038\/s41422-020-0287-8","journal-title":"Cell Res"},{"key":"5300_CR32","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/s41422-022-00639-5","volume":"32","author":"C Zhou","year":"2022","unstructured":"Zhou C, Ma L, Xu H, Huo Y, Luo J (2022) Meningeal lymphatics regulate radiotherapy efficacy through modulating anti-tumor immunity. Cell Res 32:543\u2013554. https:\/\/doi.org\/10.1038\/s41422-022-00639-5","journal-title":"Cell Res"},{"key":"5300_CR33","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1152\/physrev.00050.2017","volume":"99","author":"MD Sweeney","year":"2019","unstructured":"Sweeney MD, Zhao Z, Montagne A, Nelson AR, Zlokovic BV (2019) Blood-brain barrier: from physiology to Disease and back. Physiol Rev 99:21\u201378. https:\/\/doi.org\/10.1152\/physrev.00050.2017","journal-title":"Physiol Rev"},{"key":"5300_CR34","doi-asserted-by":"publisher","unstructured":"Ratnam NM, Gilbert MR, Giles AJ (2019) Immunotherapy in CNS cancers: the role of immune cell trafficking. Neuro-oncology 21, 37\u201346, https:\/\/doi.org\/10.1093\/neuonc\/noy084","DOI":"10.1093\/neuonc\/noy084"},{"key":"5300_CR35","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1172\/jci41911","volume":"120","author":"EH Wilson","year":"2010","unstructured":"Wilson EH, Weninger W, Hunter CA (2010) Trafficking of immune cells in the central nervous system. J Clin Investig 120:1368\u20131379. https:\/\/doi.org\/10.1172\/jci41911","journal-title":"J Clin Investig"},{"key":"5300_CR36","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1016\/j.ccell.2023.04.010","volume":"41","author":"M Ramachandran","year":"2023","unstructured":"Ramachandran M et al (2023) Tailoring vascular phenotype through AAV therapy promotes anti-tumor immunity in glioma. Cancer Cell 41:1134\u20131151e1110. https:\/\/doi.org\/10.1016\/j.ccell.2023.04.010","journal-title":"Cancer Cell"},{"key":"5300_CR37","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/s41593-022-01029-1","volume":"25","author":"JA Mazzitelli","year":"2022","unstructured":"Mazzitelli JA et al (2022) Cerebrospinal fluid regulates skull bone marrow niches via direct access through dural channels. Nat Neurosci 25:555\u2013560. https:\/\/doi.org\/10.1038\/s41593-022-01029-1","journal-title":"Nat Neurosci"},{"key":"5300_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-06993-7","author":"LCD Smyth","year":"2024","unstructured":"Smyth LCD et al (2024) Identification of direct connections between the dura and the brain. Nature. https:\/\/doi.org\/10.1038\/s41586-023-06993-7","journal-title":"Nature"},{"key":"5300_CR39","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1016\/j.cell.2020.12.040","volume":"184","author":"J Rustenhoven","year":"2021","unstructured":"Rustenhoven J et al (2021) Functional characterization of the dural sinuses as a neuroimmune interface. Cell 184:1000\u20131016. e1027","journal-title":"Cell"},{"key":"5300_CR40","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12967-023-04765-5","volume":"22","author":"Y Hu","year":"2024","unstructured":"Hu Y et al (2024) Immunogram defines four cancer-immunity cycle phenotypes with distinct clonal selection patterns across solid tumors. J Transl Med 22:69. https:\/\/doi.org\/10.1186\/s12967-023-04765-5","journal-title":"J Transl Med"},{"key":"5300_CR41","doi-asserted-by":"publisher","first-page":"247","DOI":"10.2147\/itt.S305432","volume":"10","author":"M Casey","year":"2021","unstructured":"Casey M, Nakamura K (2021) The Cancer-Immunity cycle in multiple myeloma. Immunotargets Ther 10:247\u2013260. https:\/\/doi.org\/10.2147\/itt.S305432","journal-title":"Immunotargets Ther"},{"key":"5300_CR42","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/s41568-021-00339-z","volume":"21","author":"S Jhunjhunwala","year":"2021","unstructured":"Jhunjhunwala S, Hammer C, Delamarre L (2021) Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion. Nat Rev Cancer 21:298\u2013312. https:\/\/doi.org\/10.1038\/s41568-021-00339-z","journal-title":"Nat Rev Cancer"},{"key":"5300_CR43","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1056\/NEJMoa1406498","volume":"371","author":"A Snyder","year":"2014","unstructured":"Snyder A et al (2014) Genetic basis for clinical response to CTLA-4 blockade in melanoma. N Engl J Med 371:2189\u20132199. https:\/\/doi.org\/10.1056\/NEJMoa1406498","journal-title":"N Engl J Med"},{"key":"5300_CR44","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1080\/14656566.2019.1621840","volume":"20","author":"N Majd","year":"2019","unstructured":"Majd N, de Groot J (2019) Challenges and strategies for successful clinical development of immune checkpoint inhibitors in glioblastoma. Expert Opin Pharmacother 20:1609\u20131624. https:\/\/doi.org\/10.1080\/14656566.2019.1621840","journal-title":"Expert Opin Pharmacother"},{"key":"5300_CR45","doi-asserted-by":"publisher","first-page":"2576","DOI":"10.1093\/brain\/awaa179","volume":"143","author":"IF Harrison","year":"2020","unstructured":"Harrison IF et al (2020) Impaired glymphatic function and clearance of tau in an Alzheimer\u2019s disease model. Brain 143:2576\u20132593. https:\/\/doi.org\/10.1093\/brain\/awaa179","journal-title":"Brain"},{"key":"5300_CR46","doi-asserted-by":"publisher","first-page":"14815","DOI":"10.1038\/s41598-019-51373-9","volume":"9","author":"Q Ma","year":"2019","unstructured":"Ma Q et al (2019) Lymphatic outflow of cerebrospinal fluid is reduced in glioma. Sci Rep 9:14815. https:\/\/doi.org\/10.1038\/s41598-019-51373-9","journal-title":"Sci Rep"},{"key":"5300_CR47","doi-asserted-by":"publisher","first-page":"790821","DOI":"10.3389\/fonc.2021.790821","volume":"11","author":"D Xu","year":"2021","unstructured":"Xu D et al (2021) Impediment of Cerebrospinal Fluid Drainage through Glymphatic System in Glioma. Front Oncol 11:790821. https:\/\/doi.org\/10.3389\/fonc.2021.790821","journal-title":"Front Oncol"},{"key":"5300_CR48","doi-asserted-by":"publisher","first-page":"744318","DOI":"10.3389\/fonc.2021.744318","volume":"11","author":"CH Toh","year":"2021","unstructured":"Toh CH, Siow TY (2021) Factors Associated with Dysfunction of Glymphatic System in patients with glioma. Front Oncol 11:744318. https:\/\/doi.org\/10.3389\/fonc.2021.744318","journal-title":"Front Oncol"},{"key":"5300_CR49","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/s41573-022-00500-9","volume":"21","author":"TJ Lohela","year":"2022","unstructured":"Lohela TJ, Lilius TO, Nedergaard M (2022) The glymphatic system: implications for drugs for central nervous system diseases. Nat Rev Drug Discov 21:763\u2013779. https:\/\/doi.org\/10.1038\/s41573-022-00500-9","journal-title":"Nat Rev Drug Discov"},{"key":"5300_CR50","doi-asserted-by":"publisher","first-page":"eabo7649","DOI":"10.1126\/science.abo7649","volume":"380","author":"G Castellani","year":"2023","unstructured":"Castellani G, Croese T, Peralta Ramos JM, Schwartz M (2023) Transforming the understanding of brain immunity. Sci (New York N Y) 380:eabo7649. https:\/\/doi.org\/10.1126\/science.abo7649","journal-title":"Sci (New York N Y)"},{"key":"5300_CR51","doi-asserted-by":"publisher","first-page":"286","DOI":"10.4049\/jimmunol.1900838","volume":"204","author":"Z Papadopoulos","year":"2020","unstructured":"Papadopoulos Z, Herz J, Kipnis J (2020) Meningeal lymphatics: from anatomy to Central Nervous System Immune Surveillance. J Immunol (Baltimore Md : 1950) 204:286\u2013293. https:\/\/doi.org\/10.4049\/jimmunol.1900838","journal-title":"J Immunol (Baltimore Md : 1950)"},{"key":"5300_CR52","doi-asserted-by":"publisher","unstructured":"Lee-Chang C, Lesniak MS (2023) Next-generation antigen-presenting cell immune therapeutics for gliomas. J Clin Investig 133. https:\/\/doi.org\/10.1172\/jci163449","DOI":"10.1172\/jci163449"},{"key":"5300_CR53","doi-asserted-by":"publisher","unstructured":"Petrova TV, Koh GY (2020) Biological functions of lymphatic vessels. Sci (New York N Y) 369. https:\/\/doi.org\/10.1126\/science.aax4063","DOI":"10.1126\/science.aax4063"},{"key":"5300_CR54","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1038\/s41593-018-0227-9","volume":"21","author":"A Louveau","year":"2018","unstructured":"Louveau A et al (2018) CNS lymphatic drainage and neuroinflammation are regulated by meningeal lymphatic vasculature. Nat Neurosci 21:1380\u20131391. https:\/\/doi.org\/10.1038\/s41593-018-0227-9","journal-title":"Nat Neurosci"},{"key":"5300_CR55","doi-asserted-by":"publisher","first-page":"R1593","DOI":"10.1152\/ajpregu.00695.2001","volume":"282","author":"R Mollanji","year":"2002","unstructured":"Mollanji R, Bozanovic-Sosic R, Zakharov A, Makarian L, Johnston MG (2002) Blocking cerebrospinal fluid absorption through the cribriform plate increases resting intracranial pressure. Am J Physiol Regul Integr Comp Physiol 282:R1593\u20131599. https:\/\/doi.org\/10.1152\/ajpregu.00695.2001","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"5300_CR56","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/s41590-022-01158-6","volume":"23","author":"M Hsu","year":"2022","unstructured":"Hsu M et al (2022) Neuroinflammation creates an immune regulatory niche at the meningeal lymphatic vasculature near the cribriform plate. Nat Immunol 23:581\u2013593. https:\/\/doi.org\/10.1038\/s41590-022-01158-6","journal-title":"Nat Immunol"},{"key":"5300_CR57","doi-asserted-by":"publisher","unstructured":"Thomas JL, Benveniste H (2023) CSF-to-dura gateways. J Exp Med 220. https:\/\/doi.org\/10.1084\/jem.20221719","DOI":"10.1084\/jem.20221719"},{"key":"5300_CR58","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1038\/ni.2703","volume":"14","author":"TF Gajewski","year":"2013","unstructured":"Gajewski TF, Schreiber H, Fu YX (2013) Innate and adaptive immune cells in the tumor microenvironment. Nat Immunol 14:1014\u20131022. https:\/\/doi.org\/10.1038\/ni.2703","journal-title":"Nat Immunol"},{"key":"5300_CR59","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/s41392-023-01576-4","volume":"8","author":"H Ji","year":"2023","unstructured":"Ji H et al (2023) Lymph node metastasis in cancer progression: molecular mechanisms, clinical significance and therapeutic interventions. Signal Transduct Target Therapy 8:367. https:\/\/doi.org\/10.1038\/s41392-023-01576-4","journal-title":"Signal Transduct Target Therapy"},{"key":"5300_CR60","doi-asserted-by":"publisher","first-page":"eabf9419","DOI":"10.1126\/science.abf9419","volume":"375","author":"TN Schumacher","year":"2022","unstructured":"Schumacher TN, Thommen DS (2022) Tertiary lymphoid structures in cancer. Sci (New York N Y) 375:eabf9419. https:\/\/doi.org\/10.1126\/science.abf9419","journal-title":"Sci (New York N Y)"},{"key":"5300_CR61","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/ncb3090","volume":"17","author":"W Zhou","year":"2015","unstructured":"Zhou W et al (2015) Periostin secreted by glioblastoma stem cells recruits M2 tumour-associated macrophages and promotes malignant growth. Nat Cell Biol 17:170\u2013182. https:\/\/doi.org\/10.1038\/ncb3090","journal-title":"Nat Cell Biol"},{"key":"5300_CR62","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.1158\/0008-5472.Can-16-2310","volume":"77","author":"Z Chen","year":"2017","unstructured":"Chen Z et al (2017) Cellular and Molecular Identity of Tumor-Associated macrophages in Glioblastoma. Cancer Res 77:2266\u20132278. https:\/\/doi.org\/10.1158\/0008-5472.Can-16-2310","journal-title":"Cancer Res"},{"key":"5300_CR63","doi-asserted-by":"publisher","first-page":"2582","DOI":"10.1038\/s41467-021-22885-8","volume":"12","author":"Z Amoozgar","year":"2021","unstructured":"Amoozgar Z et al (2021) Targeting Treg cells with GITR activation alleviates resistance to immunotherapy in murine glioblastomas. Nat Commun 12:2582. https:\/\/doi.org\/10.1038\/s41467-021-22885-8","journal-title":"Nat Commun"},{"key":"5300_CR64","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.1002\/stem.2393","volume":"34","author":"B Otvos","year":"2016","unstructured":"Otvos B et al (2016) Cancer Stem Cell-secreted Macrophage Migration Inhibitory factor stimulates myeloid derived suppressor cell function and facilitates Glioblastoma Immune Evasion. Stem Cells 34:2026\u20132039. https:\/\/doi.org\/10.1002\/stem.2393","journal-title":"Stem Cells"},{"key":"5300_CR65","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1093\/neuonc\/nor042","volume":"13","author":"B Raychaudhuri","year":"2011","unstructured":"Raychaudhuri B et al (2011) Myeloid-derived suppressor cell accumulation and function in patients with newly diagnosed glioblastoma. Neurooncology 13:591\u2013599. https:\/\/doi.org\/10.1093\/neuonc\/nor042","journal-title":"Neurooncology"},{"key":"5300_CR66","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1038\/s41591-018-0135-2","volume":"24","author":"P Chongsathidkiet","year":"2018","unstructured":"Chongsathidkiet P et al (2018) Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumors. Nat Med 24:1459\u20131468. https:\/\/doi.org\/10.1038\/s41591-018-0135-2","journal-title":"Nat Med"},{"key":"5300_CR67","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/nn.4185","volume":"19","author":"D Hambardzumyan","year":"2016","unstructured":"Hambardzumyan D, Gutmann DH, Kettenmann H (2016) The role of microglia and macrophages in glioma maintenance and progression. Nat Neurosci 19:20\u201327. https:\/\/doi.org\/10.1038\/nn.4185","journal-title":"Nat Neurosci"},{"key":"5300_CR68","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s41698-023-00431-7","volume":"7","author":"F Tang","year":"2023","unstructured":"Tang F et al (2023) Tumor-associated macrophage-related strategies for glioma immunotherapy. Npj Precision Oncol 7:78. https:\/\/doi.org\/10.1038\/s41698-023-00431-7","journal-title":"Npj Precision Oncol"},{"key":"5300_CR69","doi-asserted-by":"publisher","first-page":"974996","DOI":"10.3389\/fimmu.2022.974996","volume":"13","author":"C Xu","year":"2022","unstructured":"Xu C et al (2022) Origin, activation, and targeted therapy of glioma-associated macrophages. Front Immunol 13:974996. https:\/\/doi.org\/10.3389\/fimmu.2022.974996","journal-title":"Front Immunol"},{"key":"5300_CR70","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nature22396","volume":"545","author":"SR Gordon","year":"2017","unstructured":"Gordon SR et al (2017) PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity. Nature 545:495\u2013499. https:\/\/doi.org\/10.1038\/nature22396","journal-title":"Nature"},{"key":"5300_CR71","doi-asserted-by":"publisher","first-page":"588552","DOI":"10.3389\/fimmu.2020.588552","volume":"11","author":"Z Zhu","year":"2020","unstructured":"Zhu Z et al (2020) PD-L1-Mediated immunosuppression in Glioblastoma is Associated with the infiltration and M2-Polarization of Tumor-Associated macrophages. Front Immunol 11:588552. https:\/\/doi.org\/10.3389\/fimmu.2020.588552","journal-title":"Front Immunol"},{"key":"5300_CR72","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1038\/s41598-022-06430-1","volume":"12","author":"J Fierro Jr","year":"2022","unstructured":"Fierro J Jr. et al (2022) Dual-sgRNA CRISPR\/Cas9 knockout of PD-L1 in human U87 glioblastoma tumor cells inhibits proliferation, invasion, and tumor-associated macrophage polarization. Sci Rep 12:2417. https:\/\/doi.org\/10.1038\/s41598-022-06430-1","journal-title":"Sci Rep"},{"key":"5300_CR73","doi-asserted-by":"publisher","first-page":"3424","DOI":"10.1038\/s41467-021-23832-3","volume":"12","author":"F Yang","year":"2021","unstructured":"Yang F et al (2021) Synergistic immunotherapy of glioblastoma by dual targeting of IL-6 and CD40. Nat Commun 12:3424. https:\/\/doi.org\/10.1038\/s41467-021-23832-3","journal-title":"Nat Commun"},{"key":"5300_CR74","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1215\/15228517-2006-006","volume":"8","author":"A El Andaloussi","year":"2006","unstructured":"El Andaloussi A, Lesniak MS (2006) An increase in CD4\u2009+\u2009CD25\u2009+\u2009FOXP3\u2009+\u2009regulatory T cells in tumor-infiltrating lymphocytes of human glioblastoma multiforme. Neurooncology 8:234\u2013243. https:\/\/doi.org\/10.1215\/15228517-2006-006","journal-title":"Neurooncology"},{"key":"5300_CR75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biocel.2016.09.013","volume":"81","author":"Z Li","year":"2016","unstructured":"Li Z, Liu X, Guo R, Wang P (2016) CD4(+)Foxp3(-) type 1 regulatory T cells in glioblastoma multiforme suppress T cell responses through multiple pathways and are regulated by tumor-associated macrophages. Int J Biochem Cell Biol 81:1\u20139. https:\/\/doi.org\/10.1016\/j.biocel.2016.09.013","journal-title":"Int J Biochem Cell Biol"},{"key":"5300_CR76","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1093\/neuonc\/nos014","volume":"14","author":"CA Crane","year":"2012","unstructured":"Crane CA, Ahn BJ, Han SJ, Parsa AT (2012) Soluble factors secreted by glioblastoma cell lines facilitate recruitment, survival, and expansion of regulatory T cells: implications for immunotherapy. Neurooncology 14:584\u2013595. https:\/\/doi.org\/10.1093\/neuonc\/nos014","journal-title":"Neurooncology"},{"key":"5300_CR77","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/labinvest.2017.19","volume":"97","author":"A Gieryng","year":"2017","unstructured":"Gieryng A, Pszczolkowska D, Walentynowicz KA, Rajan WD, Kaminska B (2017) Immune microenvironment of gliomas. Lab Invest 97:498\u2013518. https:\/\/doi.org\/10.1038\/labinvest.2017.19","journal-title":"Lab Invest"},{"key":"5300_CR78","doi-asserted-by":"publisher","unstructured":"Peereboom DM et al (2019) Metronomic capecitabine as an immune modulator in glioblastoma patients reduces myeloid-derived suppressor cells. JCI Insight 4. https:\/\/doi.org\/10.1172\/jci.insight.130748","DOI":"10.1172\/jci.insight.130748"},{"key":"5300_CR79","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s11060-010-0473-5","volume":"104","author":"X Zhu","year":"2011","unstructured":"Zhu X, Fujita M, Snyder LA, Okada H (2011) Systemic delivery of neutralizing antibody targeting CCL2 for glioma therapy. J Neurooncol 104:83\u201392. https:\/\/doi.org\/10.1007\/s11060-010-0473-5","journal-title":"J Neurooncol"},{"key":"5300_CR80","doi-asserted-by":"publisher","unstructured":"Simonds EF et al (2021) Deep immune profiling reveals targetable mechanisms of immune evasion in immune checkpoint inhibitor-refractory glioblastoma. J Immunother Cancer 9. https:\/\/doi.org\/10.1136\/jitc-2020-002181","DOI":"10.1136\/jitc-2020-002181"},{"key":"5300_CR81","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1093\/neuonc\/noac138","volume":"25","author":"M Friedrich","year":"2023","unstructured":"Friedrich M et al (2023) Dysfunctional dendritic cells limit antigen-specific T cell response in glioma. Neurooncology 25:263\u2013276. https:\/\/doi.org\/10.1093\/neuonc\/noac138","journal-title":"Neurooncology"},{"key":"5300_CR82","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/s41586-019-1836-5","volume":"576","author":"CS Jansen","year":"2019","unstructured":"Jansen CS et al (2019) An intra-tumoral niche maintains and differentiates stem-like CD8 T cells. Nature 576:465\u2013470. https:\/\/doi.org\/10.1038\/s41586-019-1836-5","journal-title":"Nature"},{"key":"5300_CR83","doi-asserted-by":"publisher","first-page":"4127","DOI":"10.1038\/s41467-021-24347-7","volume":"12","author":"L van Hooren","year":"2021","unstructured":"van Hooren L et al (2021) Agonistic CD40 therapy induces tertiary lymphoid structures but impairs responses to checkpoint blockade in glioma. Nat Commun 12:4127. https:\/\/doi.org\/10.1038\/s41467-021-24347-7","journal-title":"Nat Commun"},{"key":"5300_CR84","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/s41568-019-0144-6","volume":"19","author":"C Saut\u00e8s-Fridman","year":"2019","unstructured":"Saut\u00e8s-Fridman C, Petitprez F, Calderaro J, Fridman WH (2019) Tertiary lymphoid structures in the era of cancer immunotherapy. Nat Rev Cancer 19:307\u2013325. https:\/\/doi.org\/10.1038\/s41568-019-0144-6","journal-title":"Nat Rev Cancer"},{"key":"5300_CR85","doi-asserted-by":"publisher","first-page":"S33","DOI":"10.1016\/j.jaci.2009.09.017","volume":"125","author":"FA Bonilla","year":"2010","unstructured":"Bonilla FA, Oettgen HC (2010) Adaptive immunity. J Allergy Clin Immunol 125:S33\u2013S40. https:\/\/doi.org\/10.1016\/j.jaci.2009.09.017","journal-title":"J Allergy Clin Immunol"},{"key":"5300_CR86","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/j.cell.2021.01.022","volume":"184","author":"ND Mathewson","year":"2021","unstructured":"Mathewson ND et al (2021) Inhibitory CD161 receptor identified in glioma-infiltrating T cells by single-cell analysis. Cell 184:1281\u20131298e1226. https:\/\/doi.org\/10.1016\/j.cell.2021.01.022","journal-title":"Cell"},{"key":"5300_CR87","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1158\/1078-0432.Ccr-21-0947","volume":"28","author":"JL Campian","year":"2022","unstructured":"Campian JL et al (2022) Long-acting recombinant human Interleukin-7, NT-I7, increases cytotoxic CD8 T cells and enhances survival in mouse glioma models. Clin Cancer Res 28:1229\u20131239. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-21-0947","journal-title":"Clin Cancer Res"},{"key":"5300_CR88","doi-asserted-by":"publisher","first-page":"2898","DOI":"10.1158\/1078-0432.Ccr-21-2830","volume":"28","author":"A Kumar","year":"2022","unstructured":"Kumar A et al (2022) CXCL14 promotes a Robust Brain Tumor-Associated Immune Response in Glioma. Clin Cancer Res 28:2898\u20132910. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-21-2830","journal-title":"Clin Cancer Res"},{"key":"5300_CR89","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1038\/s41467-022-28523-1","volume":"13","author":"VM Ravi","year":"2022","unstructured":"Ravi VM et al (2022) T-cell dysfunction in the glioblastoma microenvironment is mediated by myeloid cells releasing interleukin-10. Nat Commun 13:925. https:\/\/doi.org\/10.1038\/s41467-022-28523-1","journal-title":"Nat Commun"},{"key":"5300_CR90","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/s41593-019-0370-y","volume":"22","author":"MC Takenaka","year":"2019","unstructured":"Takenaka MC et al (2019) Control of tumor-associated macrophages and T cells in glioblastoma via AHR and CD39. Nat Neurosci 22:729\u2013740. https:\/\/doi.org\/10.1038\/s41593-019-0370-y","journal-title":"Nat Neurosci"},{"key":"5300_CR91","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/s41467-020-20599-x","volume":"12","author":"G Agliardi","year":"2021","unstructured":"Agliardi G et al (2021) Intratumoral IL-12 delivery empowers CAR-T cell immunotherapy in a pre-clinical model of glioblastoma. Nat Commun 12:444. https:\/\/doi.org\/10.1038\/s41467-020-20599-x","journal-title":"Nat Commun"},{"key":"5300_CR92","doi-asserted-by":"publisher","first-page":"5671","DOI":"10.1158\/0008-5472.Can-16-0144","volume":"76","author":"AL Chang","year":"2016","unstructured":"Chang AL et al (2016) CCL2 produced by the Glioma Microenvironment is essential for the Recruitment of Regulatory T Cells and myeloid-derived suppressor cells. Cancer Res 76:5671\u20135682. https:\/\/doi.org\/10.1158\/0008-5472.Can-16-0144","journal-title":"Cancer Res"},{"key":"5300_CR93","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s11060-006-9274-2","volume":"82","author":"O Grauer","year":"2007","unstructured":"Grauer O, P\u00f6schl P, Lohmeier A, Adema GJ, Bogdahn U (2007) Toll-like receptor triggered dendritic cell maturation and IL-12 secretion are necessary to overcome T-cell inhibition by glioma-associated TGF-beta2. J Neurooncol 82:151\u2013161. https:\/\/doi.org\/10.1007\/s11060-006-9274-2","journal-title":"J Neurooncol"},{"key":"5300_CR94","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1186\/s40425-019-0809-4","volume":"7","author":"F Dastmalchi","year":"2019","unstructured":"Dastmalchi F et al (2019) Sarcosine promotes trafficking of dendritic cells and improves efficacy of anti-tumor dendritic cell vaccines via CXC chemokine family signaling. J Immunother Cancer 7:321. https:\/\/doi.org\/10.1186\/s40425-019-0809-4","journal-title":"J Immunother Cancer"},{"key":"5300_CR95","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s13045-021-01191-2","volume":"14","author":"Y Xun","year":"2021","unstructured":"Xun Y, Yang H, Kaminska B, You H (2021) Toll-like receptors and toll-like receptor-targeted immunotherapy against glioma. J Hematol Oncol 14:176. https:\/\/doi.org\/10.1186\/s13045-021-01191-2","journal-title":"J Hematol Oncol"},{"key":"5300_CR96","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1038\/nm.3337","volume":"19","author":"SM Pyonteck","year":"2013","unstructured":"Pyonteck SM et al (2013) CSF-1R inhibition alters macrophage polarization and blocks glioma progression. Nat Med 19:1264\u20131272. https:\/\/doi.org\/10.1038\/nm.3337","journal-title":"Nat Med"},{"key":"5300_CR97","doi-asserted-by":"publisher","first-page":"15286","DOI":"10.1038\/s41598-020-71857-3","volume":"10","author":"K Shono","year":"2020","unstructured":"Shono K et al (2020) Downregulation of the CCL2\/CCR2 and CXCL10\/CXCR3 axes contributes to antitumor effects in a mouse model of malignant glioma. Sci Rep 10:15286. https:\/\/doi.org\/10.1038\/s41598-020-71857-3","journal-title":"Sci Rep"},{"key":"5300_CR98","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1007\/s00262-020-02569-w","volume":"69","author":"JH Azambuja","year":"2020","unstructured":"Azambuja JH et al (2020) Blockade of CD73 delays glioblastoma growth by modulating the immune environment. Cancer Immunol Immunother 69:1801\u20131812. https:\/\/doi.org\/10.1007\/s00262-020-02569-w","journal-title":"Cancer Immunol Immunother"},{"key":"5300_CR99","doi-asserted-by":"publisher","first-page":"eabl5165","DOI":"10.1126\/sciadv.abl5165","volume":"8","author":"X Ni","year":"2022","unstructured":"Ni X et al (2022) Interrogating glioma-M2 macrophage interactions identifies Gal-9\/Tim-3 as a viable target against PTEN-null glioblastoma. Sci Adv 8:eabl5165. https:\/\/doi.org\/10.1126\/sciadv.abl5165","journal-title":"Sci Adv"},{"key":"5300_CR100","doi-asserted-by":"publisher","first-page":"110181","DOI":"10.1016\/j.cellsig.2021.110181","volume":"89","author":"X Cai","year":"2022","unstructured":"Cai X, Tao W, Li L (2022) Glioma cell-derived FGF20 suppresses macrophage function by activating \u03b2-catenin. Cell Signal 89:110181. https:\/\/doi.org\/10.1016\/j.cellsig.2021.110181","journal-title":"Cell Signal"},{"key":"5300_CR101","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1172\/jci121266","volume":"129","author":"J Wei","year":"2019","unstructured":"Wei J et al (2019) Osteopontin mediates glioblastoma-associated macrophage infiltration and is a potential therapeutic target. J Clin Investig 129:137\u2013149. https:\/\/doi.org\/10.1172\/jci121266","journal-title":"J Clin Investig"},{"key":"5300_CR102","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1093\/neuonc\/noab181","volume":"24","author":"H Huang","year":"2022","unstructured":"Huang H et al (2022) ELTD1 deletion reduces vascular abnormality and improves T-cell recruitment after PD-1 blockade in glioma. Neurooncology 24:398\u2013411. https:\/\/doi.org\/10.1093\/neuonc\/noab181","journal-title":"Neurooncology"},{"key":"5300_CR103","doi-asserted-by":"publisher","first-page":"4296","DOI":"10.1158\/1078-0432.Ccr-10-2557","volume":"17","author":"J Lohr","year":"2011","unstructured":"Lohr J et al (2011) Effector T-cell infiltration positively impacts survival of glioblastoma patients and is impaired by tumor-derived TGF-\u03b2. Clin Cancer Res 17:4296\u20134308. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-10-2557","journal-title":"Clin Cancer Res"},{"key":"5300_CR104","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/nri3442","volume":"13","author":"D Masopust","year":"2013","unstructured":"Masopust D, Schenkel JM (2013) The integration of T cell migration, differentiation and function. Nat Rev Immunol 13:309\u2013320. https:\/\/doi.org\/10.1038\/nri3442","journal-title":"Nat Rev Immunol"},{"key":"5300_CR105","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.immuni.2016.03.012","volume":"44","author":"H Salmon","year":"2016","unstructured":"Salmon H et al (2016) Expansion and activation of CD103\u2009+\u2009dendritic cell progenitors at the Tumor Site enhances tumor responses to therapeutic PD-L1 and BRAF inhibition. Immunity 44:924\u2013938. https:\/\/doi.org\/10.1016\/j.immuni.2016.03.012","journal-title":"Immunity"},{"key":"5300_CR106","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.jneuroim.2010.05.020","volume":"225","author":"JF Jacobs","year":"2010","unstructured":"Jacobs JF et al (2010) Prognostic significance and mechanism of Treg infiltration in human brain tumors. J Neuroimmunol 225:195\u2013199. https:\/\/doi.org\/10.1016\/j.jneuroim.2010.05.020","journal-title":"J Neuroimmunol"},{"key":"5300_CR107","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1038\/s41590-023-01443-y","volume":"24","author":"MM Steele","year":"2023","unstructured":"Steele MM et al (2023) T cell egress via lymphatic vessels is tuned by antigen encounter and limits tumor control. Nat Immunol 24:664\u2013675. https:\/\/doi.org\/10.1038\/s41590-023-01443-y","journal-title":"Nat Immunol"},{"key":"5300_CR108","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1084\/jem.20092465","volume":"207","author":"JN Cohen","year":"2010","unstructured":"Cohen JN et al (2010) Lymph node-resident lymphatic endothelial cells mediate peripheral tolerance via Aire-independent direct antigen presentation. J Exp Med 207:681\u2013688. https:\/\/doi.org\/10.1084\/jem.20092465","journal-title":"J Exp Med"},{"key":"5300_CR109","doi-asserted-by":"publisher","first-page":"4772","DOI":"10.1182\/blood-2012-04-427013","volume":"120","author":"EF Tewalt","year":"2012","unstructured":"Tewalt EF et al (2012) Lymphatic endothelial cells induce tolerance via PD-L1 and lack of costimulation leading to high-level PD-1 expression on CD8 T cells. Blood 120:4772\u20134782. https:\/\/doi.org\/10.1182\/blood-2012-04-427013","journal-title":"Blood"},{"key":"5300_CR110","doi-asserted-by":"publisher","first-page":"6771","DOI":"10.1038\/ncomms7771","volume":"6","author":"SJ Rouhani","year":"2015","unstructured":"Rouhani SJ et al (2015) Roles of lymphatic endothelial cells expressing peripheral tissue antigens in CD4 T-cell tolerance induction. Nat Commun 6:6771. https:\/\/doi.org\/10.1038\/ncomms7771","journal-title":"Nat Commun"},{"key":"5300_CR111","doi-asserted-by":"publisher","unstructured":"Lucas ED, Tamburini BAJ (2019) Lymph node lymphatic endothelial cell expansion and contraction and the programming of the Immune response. Front Immunol 10. https:\/\/doi.org\/10.3389\/fimmu.2019.00036","DOI":"10.3389\/fimmu.2019.00036"},{"key":"5300_CR112","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1084\/jem.20132000","volume":"211","author":"J Dubrot","year":"2014","unstructured":"Dubrot J et al (2014) Lymph node stromal cells acquire peptide-MHCII complexes from dendritic cells and induce antigen-specific CD4 T cell tolerance. J Exp Med 211:1153\u20131166. https:\/\/doi.org\/10.1084\/jem.20132000","journal-title":"J Exp Med"},{"key":"5300_CR113","doi-asserted-by":"publisher","first-page":"5002","DOI":"10.4049\/jimmunol.1302492","volume":"192","author":"S Hirosue","year":"2014","unstructured":"Hirosue S et al (2014) Steady-state antigen scavenging, cross-presentation, and CD8\u2009+\u2009T cell priming: a new role for lymphatic endothelial cells. J Immunol (Baltimore Md : 1950) 192:5002\u20135011. https:\/\/doi.org\/10.4049\/jimmunol.1302492","journal-title":"J Immunol (Baltimore Md : 1950)"},{"key":"5300_CR114","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/s41467-019-14127-9","volume":"11","author":"E Vokali","year":"2020","unstructured":"Vokali E et al (2020) Lymphatic endothelial cells prime na\u00efve CD8(+) T cells into memory cells under steady-state conditions. Nat Commun 11:538. https:\/\/doi.org\/10.1038\/s41467-019-14127-9","journal-title":"Nat Commun"},{"key":"5300_CR115","doi-asserted-by":"publisher","first-page":"4133","DOI":"10.1158\/0008-5472.Can-21-0633","volume":"81","author":"N Cousin","year":"2021","unstructured":"Cousin N et al (2021) Lymphatic PD-L1 expression restricts tumor-specific CD8(+) T-cell responses. Cancer Res 81:4133\u20134144. https:\/\/doi.org\/10.1158\/0008-5472.Can-21-0633","journal-title":"Cancer Res"},{"key":"5300_CR116","doi-asserted-by":"publisher","first-page":"eabl5162","DOI":"10.1126\/sciadv.abl5162","volume":"8","author":"L Garnier","year":"2022","unstructured":"Garnier L et al (2022) IFN-\u03b3-dependent tumor-antigen cross-presentation by lymphatic endothelial cells promotes their killing by T cells and inhibits metastasis. Sci Adv 8:eabl5162. https:\/\/doi.org\/10.1126\/sciadv.abl5162","journal-title":"Sci Adv"},{"key":"5300_CR117","doi-asserted-by":"publisher","first-page":"477","DOI":"10.3389\/fimmu.2016.00477","volume":"7","author":"F Barone","year":"2016","unstructured":"Barone F et al (2016) Stromal fibroblasts in Tertiary lymphoid structures: a novel target in chronic inflammation. Front Immunol 7:477. https:\/\/doi.org\/10.3389\/fimmu.2016.00477","journal-title":"Front Immunol"},{"key":"5300_CR118","doi-asserted-by":"publisher","first-page":"e28976","DOI":"10.4161\/onci.28976","volume":"3","author":"J Goc","year":"2014","unstructured":"Goc J, Fridman WH, Hammond SA, Saut\u00e8s-Fridman C, Dieu-Nosjean MC (2014) Tertiary lymphoid structures in human lung cancers, a new driver of antitumor immune responses. Oncoimmunology 3:e28976. https:\/\/doi.org\/10.4161\/onci.28976","journal-title":"Oncoimmunology"},{"key":"5300_CR119","doi-asserted-by":"publisher","first-page":"e1378844","DOI":"10.1080\/2162402x.2017.1378844","volume":"7","author":"F Posch","year":"2018","unstructured":"Posch F et al (2018) Maturation of tertiary lymphoid structures and recurrence of stage II and III colorectal cancer. Oncoimmunology 7:e1378844. https:\/\/doi.org\/10.1080\/2162402x.2017.1378844","journal-title":"Oncoimmunology"},{"key":"5300_CR120","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1038\/bjc.2015.145","volume":"112","author":"N Hiraoka","year":"2015","unstructured":"Hiraoka N et al (2015) Intratumoral tertiary lymphoid organ is a favourable prognosticator in patients with pancreatic cancer. Br J Cancer 112:1782\u20131790. https:\/\/doi.org\/10.1038\/bjc.2015.145","journal-title":"Br J Cancer"},{"key":"5300_CR121","doi-asserted-by":"publisher","unstructured":"M\u00f8llg\u00e5rd K et al (2023) A mesothelium divides the subarachnoid space into functional compartments. 379:84\u201388. https:\/\/doi.org\/10.1126\/science.adc8810","DOI":"10.1126\/science.adc8810"},{"key":"5300_CR122","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1158\/2326-6066.Cir-14-0027","volume":"2","author":"ER Lutz","year":"2014","unstructured":"Lutz ER et al (2014) Immunotherapy converts nonimmunogenic pancreatic tumors into immunogenic foci of immune regulation. Cancer Immunol Res 2:616\u2013631. https:\/\/doi.org\/10.1158\/2326-6066.Cir-14-0027","journal-title":"Cancer Immunol Res"},{"key":"5300_CR123","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/s41586-019-1922-8","volume":"577","author":"BA Helmink","year":"2020","unstructured":"Helmink BA et al (2020) B cells and tertiary lymphoid structures promote immunotherapy response. Nature 577:549\u2013555. https:\/\/doi.org\/10.1038\/s41586-019-1922-8","journal-title":"Nature"},{"key":"5300_CR124","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/s41586-019-1914-8","volume":"577","author":"R Cabrita","year":"2020","unstructured":"Cabrita R et al (2020) Tertiary lymphoid structures improve immunotherapy and survival in melanoma. Nature 577:561\u2013565. https:\/\/doi.org\/10.1038\/s41586-019-1914-8","journal-title":"Nature"},{"key":"5300_CR125","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1038\/s41591-020-1086-y","volume":"26","author":"J Gao","year":"2020","unstructured":"Gao J et al (2020) Neoadjuvant PD-L1 plus CTLA-4 blockade in patients with cisplatin-ineligible operable high-risk urothelial carcinoma. Nat Med 26:1845\u20131851. https:\/\/doi.org\/10.1038\/s41591-020-1086-y","journal-title":"Nat Med"},{"key":"5300_CR126","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1038\/ni.3836","volume":"18","author":"A Johansson-Percival","year":"2017","unstructured":"Johansson-Percival A et al (2017) De novo induction of intratumoral lymphoid structures and vessel normalization enhances immunotherapy in resistant tumors. Nat Immunol 18:1207\u20131217. https:\/\/doi.org\/10.1038\/ni.3836","journal-title":"Nat Immunol"},{"key":"5300_CR127","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1038\/ni.3290","volume":"16","author":"S Finkin","year":"2015","unstructured":"Finkin S et al (2015) Ectopic lymphoid structures function as microniches for tumor progenitor cells in hepatocellular carcinoma. Nat Immunol 16:1235\u20131244. https:\/\/doi.org\/10.1038\/ni.3290","journal-title":"Nat Immunol"},{"key":"5300_CR128","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.immuni.2015.08.006","volume":"43","author":"NS Joshi","year":"2015","unstructured":"Joshi NS et al (2015) Regulatory T cells in Tumor-Associated Tertiary lymphoid structures suppress anti-tumor T cell responses. Immunity 43:579\u2013590. https:\/\/doi.org\/10.1016\/j.immuni.2015.08.006","journal-title":"Immunity"},{"key":"5300_CR129","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/s43018-023-00547-6","volume":"4","author":"L van Hooren","year":"2023","unstructured":"van Hooren L et al (2023) CD103\u2009+\u2009regulatory T cells underlie resistance to radio-immunotherapy and impair CD8\u2009+\u2009T cell activation in glioblastoma. Nat Cancer 4:665\u2013681. https:\/\/doi.org\/10.1038\/s43018-023-00547-6","journal-title":"Nat Cancer"},{"key":"5300_CR130","doi-asserted-by":"publisher","unstructured":"Brioschi S et al (2021) Heterogeneity of meningeal B cells reveals a lymphopoietic niche at the CNS borders. Sci (New York N Y) 373. https:\/\/doi.org\/10.1126\/science.abf9277","DOI":"10.1126\/science.abf9277"},{"key":"5300_CR131","doi-asserted-by":"publisher","first-page":"2784","DOI":"10.1016\/j.immuni.2021.09.016","volume":"54","author":"Y Wang","year":"2021","unstructured":"Wang Y et al (2021) Early developing B cells undergo negative selection by central nervous system-specific antigens in the meninges. Immunity 54:2784\u20132794e2786. https:\/\/doi.org\/10.1016\/j.immuni.2021.09.016","journal-title":"Immunity"},{"key":"5300_CR132","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-024-07202-9","author":"Z Fitzpatrick","year":"2024","unstructured":"Fitzpatrick Z et al (2024) Venous-plexus-associated lymphoid hubs support meningeal humoral immunity. Nature. https:\/\/doi.org\/10.1038\/s41586-024-07202-9","journal-title":"Nature"},{"key":"5300_CR133","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1111\/imm.13395","volume":"164","author":"J Zhan","year":"2021","unstructured":"Zhan J, Kipp M, Han W, Kaddatz H (2021) Ectopic lymphoid follicles in progressive multiple sclerosis: from patients to animal models. Immunology 164:450\u2013466. https:\/\/doi.org\/10.1111\/imm.13395","journal-title":"Immunology"},{"key":"5300_CR134","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/j.immuni.2011.10.015","volume":"35","author":"A Peters","year":"2011","unstructured":"Peters A et al (2011) Th17 cells induce ectopic lymphoid follicles in central nervous system tissue inflammation. Immunity 35:986\u2013996. https:\/\/doi.org\/10.1016\/j.immuni.2011.10.015","journal-title":"Immunity"},{"key":"5300_CR135","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1007\/s00401-012-1023-3","volume":"124","author":"S Kuerten","year":"2012","unstructured":"Kuerten S et al (2012) Tertiary lymphoid organ development coincides with determinant spreading of the myelin-specific T cell response. Acta Neuropathol 124:861\u2013873. https:\/\/doi.org\/10.1007\/s00401-012-1023-3","journal-title":"Acta Neuropathol"},{"key":"5300_CR136","doi-asserted-by":"publisher","unstructured":"Cohen M et al (2021) Meningeal lymphoid structures are activated under acute and chronic spinal cord pathologies. Life Sci Alliance 4. https:\/\/doi.org\/10.26508\/lsa.202000907","DOI":"10.26508\/lsa.202000907"},{"key":"5300_CR137","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/s41586-019-1419-5","volume":"572","author":"JH Ahn","year":"2019","unstructured":"Ahn JH et al (2019) Meningeal lymphatic vessels at the skull base drain cerebrospinal fluid. Nature 572:62\u201366. https:\/\/doi.org\/10.1038\/s41586-019-1419-5","journal-title":"Nature"},{"key":"5300_CR138","doi-asserted-by":"publisher","unstructured":"Cugurra A et al (2021) Skull and vertebral bone marrow are myeloid cell reservoirs for the meninges and CNS parenchyma. Sci (New York N Y) 373. https:\/\/doi.org\/10.1126\/science.abf7844","DOI":"10.1126\/science.abf7844"},{"key":"5300_CR139","doi-asserted-by":"publisher","first-page":"3056","DOI":"10.1016\/j.cell.2021.04.003","volume":"184","author":"N Dani","year":"2021","unstructured":"Dani N et al (2021) A cellular and spatial map of the choroid plexus across brain ventricles and ages. Cell 184:3056\u20133074e3021. https:\/\/doi.org\/10.1016\/j.cell.2021.04.003","journal-title":"Cell"},{"key":"5300_CR140","doi-asserted-by":"publisher","first-page":"4674","DOI":"10.1172\/jci86950","volume":"126","author":"G Faraco","year":"2016","unstructured":"Faraco G et al (2016) Perivascular macrophages mediate the neurovascular and cognitive dysfunction associated with hypertension. J Clin Investig 126:4674\u20134689. https:\/\/doi.org\/10.1172\/jci86950","journal-title":"J Clin Investig"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-024-05300-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00018-024-05300-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-024-05300-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T19:04:12Z","timestamp":1731351852000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00018-024-05300-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,22]]},"references-count":140,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["5300"],"URL":"https:\/\/doi.org\/10.1007\/s00018-024-05300-5","relation":{},"ISSN":["1420-682X","1420-9071"],"issn-type":[{"value":"1420-682X","type":"print"},{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,22]]},"assertion":[{"value":"2 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors give consent for the publication of the manuscript in CMLS.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"275"}}